14 episodes

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Ophthalmology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in ophthalmology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.

CME in Minutes: Education in Ophthalmology Answers In CME

    • Science

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Ophthalmology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in ophthalmology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.

    Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician

    Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician

    Please visit answersincme.com/WZP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert dermatologist—who is also an early adopter of generative artificial intelligence (AI)—discusses foundational elements of this emerging technology and its implications in healthcare, both for clinicians and patients. Upon completion of this activity, participants should be better able to: Describe how generative AI is impacting the practice of medicine both from the clinicians’ and patients’ perspectives; and Assess the potential benefits and risks of using generative AI in medical practice.

    • 14 min
    Diana V. Do, MD - An Eye Toward Improving the Management of DME: Diagnosis and Shared Decision-Making

    Diana V. Do, MD - An Eye Toward Improving the Management of DME: Diagnosis and Shared Decision-Making

    Please visit answersincme.com/FZX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses the diagnosis and treatment of diabetic macular edema (DME), including the role of shared decision-making, with a patient’s perspective. Upon completion of this activity, participants should be better able to: Recognize best practices to achieve a prompt and accurate diagnosis of DME; Describe guideline-concordant, evidence-based strategies to select appropriate therapy for patients with DME; Review the clinical profiles of longer-acting VEGF-targeted agents with phase 3 trial evidence in the treatment of DME; and Outline patient-centered management approaches to improve adherence to VEGF-targeted therapy among patients with DME.

    • 19 min
    Talia Kaden, MD - Considerations for Identifying the Right Patient for Intravitreal Anti-VEGF Injections in nAMD

    Talia Kaden, MD - Considerations for Identifying the Right Patient for Intravitreal Anti-VEGF Injections in nAMD

    Please visit answersincme.com/HEQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses how to optimize the use of intravitreal anti-vascular endothelial growth factor (VEGF) therapies in patients with neovascular age-related macular degeneration (nAMD) using a case-based approach with perspectives from a patient. Upon completion of this activity, participants should be better able to: Describe the latest evidence for anti-VEGF therapies used in the treatment of nAMD; Outline practical strategies to optimize the use of anti-VEGF therapies in the management of nAMD; and Explain the importance of shared decision-making in the management of nAMD.

    • 19 min
    Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents

    Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents

    Please visit answersincme.com/YSM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in ophthalmology discuss timely diagnosis of diabetic macular edema (DME) and treatment with anti–vascular endothelial growth factor (VEGF) agents. Upon completion of this activity, participants should be better able to: Recognize best practices to achieve a prompt and accurate diagnosis of DME; Describe guideline-concordant, evidence-based strategies to select appropriate therapy for patients with DME; and Review the clinical profiles of longer-acting VEGF-targeted agents with phase 3 trial evidence in the treatment of DME.

    • 18 min
    David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents

    David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents

    Please visit answersincme.com/YYB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses strategies for selecting anti-VEGF therapy and maintaining adherence for patients with diabetic macular edema. Upon completion of this activity, participants should be better able to: Describe guideline-concordant, evidence-based strategies to select appropriate therapy for patients with diabetic macular edema (DME); Review the clinical profiles of longer-acting vascular endothelial growth factor (VEGF)-targeted agents with phase 3 trial evidence in the treatment of DME; and Outline patient-centered management approaches to improve adherence to VEGF-targeted therapy.

    • 14 min
    W. Lloyd Clark, MD - The Urgency of Retinal Vein Occlusion: Timely Detection, Referral, and Management

    W. Lloyd Clark, MD - The Urgency of Retinal Vein Occlusion: Timely Detection, Referral, and Management

    Please visit answersincme.com/MUP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses the importance of early detection and referral of patients with retinal vein occlusion (RVO), as well as a personalized and multidisciplinary approach to management. Upon completion of this activity, participants should be better able to: Recognize the rationale for early detection of RVO; Describe the appropriate processes for timely referral of patients with RVO; and Outline strategies for personalized, multidisciplinary management of patients with RVO.

    • 13 min

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Radiolab
WNYC Studios
Making Sense with Sam Harris
Sam Harris
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson